GBS Inc. (NYSE:GBS – Get Free Report)’s share price traded down 0.5% during trading on Thursday . The stock traded as low as $1.86 and last traded at $1.90. 60,577 shares were traded during trading, a decline of 94% from the average session volume of 955,325 shares. The stock had previously closed at $1.91.
GBS Stock Performance
The company has a 50-day moving average of $1.40 and a 200 day moving average of $1.62. The firm has a market cap of $28.29 million, a P/E ratio of -3.39 and a beta of 1.32.
About GBS
GBS Inc operates as a biosensor diagnostic technology company in the Asia-Pacific and North America. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities.
Featured Stories
- Five stocks we like better than GBS
- How is Compound Interest Calculated?
- Robinhood Director Sells Millions, But HOOD Stock Eyes Gains
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Coinbase Stock Pops as Senate Passes GENIUS Stablecoin Bill
- Most active stocks: Dollar volume vs share volume
- Super Micro Computer Stock’s Rally Backed by Strong Financials
Receive News & Ratings for GBS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GBS and related companies with MarketBeat.com's FREE daily email newsletter.
